Published in Nouv Rev Fr Hematol on October 27, 1970
Ehlers-Danlos syndrome, clotting disorders and muscular dystrophy. Ann Rheum Dis (1989) 0.77
Bleeding in renal failure: a possible cause. Br Med J (1976) 2.82
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet (1984) 2.47
Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J (1989) 2.37
Increase of endothelial cell growth by sera from diabetic patients with proliferative retinopathy. Lancet (1989) 2.05
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med (1976) 1.58
Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg (1998) 1.52
Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. Proc Natl Acad Sci U S A (1987) 1.49
Listeria monocytogenes causing hospital-acquired enterocolitis and meningitis in newborn infants. Br Med J (1978) 1.47
Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Clin Invest (1980) 1.45
Platelet aggregation induced by type IIb platelet von Willebrand factor. Br J Haematol (1989) 1.42
Use of dexamethasone in treatment of enteric fever complicated by cerebellar involvement. Trans R Soc Trop Med Hyg (1994) 1.39
Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer (1996) 1.36
Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Thromb Haemost (1983) 1.34
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother (1999) 1.33
Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage. J Lab Clin Med (1979) 1.31
Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment. Blood Rev (2002) 1.31
Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol (1984) 1.29
Availability of platelet Factor 3 and activation of factor XII in thrombasthenia. Nature (1965) 1.20
Monoclonal antibody to human platelet glycoprotein I. I. Immunological studies. Br J Haematol (1981) 1.18
Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. secretariat.haemophiles@cch.ap-hop-paris.fr. Haemophilia (2000) 1.18
Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? J Antimicrob Chemother (1990) 1.17
Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol (1981) 1.15
Von Willebrand's disease: combined qualitative and quantitative abnormalities. N Engl J Med (1977) 1.14
Clinical aspects on 64 cases of juvenile and adult listeriosis in Sweden. Acta Med Scand (1978) 1.14
Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost (1997) 1.12
Binding and endocytosis of heparin by human endothelial cells in culture. Biochim Biophys Acta (1985) 1.11
Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol (1981) 1.11
Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Ther (1998) 1.10
Structural and functional features of glycosyltransferases. Biochimie (2001) 1.10
Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N Engl J Med (1986) 1.10
In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease. Proc Natl Acad Sci U S A (1985) 1.08
Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J (1991) 1.08
Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis (2000) 1.08
Aggregation, adhesion, and viscous metamorphosis of platelets in congenital fibrinogen deficiencies. J Lab Clin Med (1966) 1.07
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med (1990) 1.07
Regulation of calcium accumulation and efflux from platelet vesicles. Possible role for cyclic-AMP-dependent phosphorylation and calmodulin. Biochim Biophys Acta (1983) 1.07
Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease. J Clin Pathol (1975) 1.04
New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol (1985) 1.03
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. J Clin Invest (1975) 1.03
Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function. J Lab Clin Med (1981) 1.03
Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins. Clin Exp Immunol (1988) 1.03
Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi Septicaemia. J Trop Pediatr (1995) 1.02
Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia. Scand J Haematol (1981) 1.01
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants. Science (1976) 1.01
Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci U S A (1992) 1.01
Activation of the 92 kDa type IV collagenase by tissue kallikrein. J Cell Physiol (1993) 0.99
Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation. Thromb Haemost (1988) 0.99
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood (1987) 0.97
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr Infect Dis J (1995) 0.96
[Intra-osseus hemorrhagic lesions in congenital afibrinogenemia. A new case (author's transl)]. J Radiol (1981) 0.96
Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med (1999) 0.96
Occurrence of arteriosclerosis in von Willebrand's disease. Acta Med Scand (1966) 0.96
In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs. Arterioscler Thromb Vasc Biol (1999) 0.96
Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response. Blood (2001) 0.96
Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. J Health Popul Nutr (2000) 0.95
Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia. Thromb Res (1996) 0.95
[Elastinolytic activity associated with blood platelets]. Pathol Biol (Paris) (1970) 0.95
The effect of platelets on invasiveness and protease production of human mammary tumor cells. Int J Cancer (1995) 0.94
Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient. Proc Natl Acad Sci U S A (1990) 0.93
Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes. J Immunol (1987) 0.93
[Variations of platelet sialic acid in constitutional and acquired thrombopathies]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.93
[Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers]. Nouv Rev Fr Hematol (1986) 0.93
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. J Clin Invest (1985) 0.93
Platelet aggregation in washed suspensions. Scand J Haematol (1971) 0.92
Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia (1999) 0.92
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. J Lab Clin Med (1976) 0.92
Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost (1985) 0.92
Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. Am J Trop Med Hyg (1993) 0.91
Platelet fibrinogen. J Clin Pathol (1965) 0.91
Hypofibrinogenaemia and massive thrombosis. Acta Med Scand (1966) 0.91
Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients). Am J Med (1968) 0.91
Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease. Blood (1986) 0.90
Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol). Thromb Haemost (1991) 0.89
Studies on a human blood platelet protease with elastolytic activity. Biochim Biophys Acta (1973) 0.89
Localization of factor VIII/von Willebrand factor antigen by immunoelectron microscopy in human endothelial cells using Fab fragments coupled to peroxidase. J Histochem Cytochem (1982) 0.89
Circulating anticoagulant against factors XI and XII together with massive spontaneous platelet aggregation. Scand J Haematol (1973) 0.89
Histochemical and ultrastructural characterization of subendothelial glycoprotein microfibrils interacting with platelets. J Histochem Cytochem (1982) 0.89
Penetration of cefuroxime and doxycycline into the pleural fluid. J Antimicrob Chemother (1980) 0.89
Acute sporadic hepatitis E in an Egyptian pediatric population. Am J Trop Med Hyg (1993) 0.88
New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity. FEBS Lett (1988) 0.88
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. J Clin Invest (1988) 0.88
Von Willebrand disease as an endothelial-cell abnormality. Lancet (1975) 0.88
New data on Glanzmann's thrombasthenia. Proc Soc Exp Biol Med (1971) 0.87
Aggregation of human gel-filtered platelets. Requirement of apyrase and proteins. Rev Eur Etud Clin Biol (1972) 0.87
Cefixime in the treatment of enteric fever in children. Drugs Exp Clin Res (1993) 0.87
[Behavior of rat platelets]. Thromb Diath Haemorrh (1966) 0.87
Platelet dysfunction in preleukemic states and in various types of leukemia. Ann N Y Acad Sci (1972) 0.87
Suppressive effect of dextran on platelet adhesiveness. Thromb Diath Haemorrh (1966) 0.87
Mecillinam and ampicillin separately or combined in gram-negative septicemia. Infection (1980) 0.87
Abnormal platelet function, population, and survival-time in a boy with congenital absent radii and thrombocytopenia. Lancet (1972) 0.86
Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr Infect Dis J (1998) 0.86
Studies on the platelet adhesiveness in von Willebrand's disease. Acta Med Scand (1966) 0.86